MedTrace Logo

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

NCT05974904 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2025-02-12

No results posted yet for this study

Summary

The goal of this observational study is to investigate the associations between a novel inflammatory marker, high sensitivity C-reactiveprotein to albumin ratio (hsCAR), and steatosis and fibrosis of metabolic dysfunction-associated fatty liver disease (MAFLD).

The main question\[s\] it aims to answer are:

\[question 1\] Can hsCAR serve as a clinical indicator to determine whether a patient has MAFD? \[question 2\] Can hsCAR determine whether MAFLD patients are complicated with liver fibrosis?

Conditions

  • Metabolic Dysfunction-associated Fatty Liver Disease
  • Hepatic Steatosis
  • Liver Fibrosis

Interventions

OTHER

high-sensitivity C-reactive protein to albumin ratio

High-sensitivity C-reactive protein to albumin ratio is an inflammatory indicator which can make a determination of disease severity.

Sponsors & Collaborators

  • Chongqing Medical University

    lead OTHER

Principal Investigators

  • Tingqiu Wang, Bachelor · The Second Affiliated Hospital of Chongqing Medical University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-18
Primary Completion
2026-12-28
Completion
2026-12-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05974904 on ClinicalTrials.gov